The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 01, 2008

Filed:

Oct. 31, 2003
Applicants:

Dirk Stenkamp, Biberach, DE;

Stephan Georg Mueller, Warthausen, DE;

Gerald Juergen Roth, Biberach, DE;

Philipp Lustenberger, Warthausen, DE;

Klaus Rudolf, Warthausen, DE;

Thorsten Lehmann-lintz, Ochsenhausen, DE;

Kirsten Arndt, Biberach, DE;

Ralf Lotz, Schemmerhofen, DE;

Martin Lenter, Ulm, DE;

Heike-andrea Wieland, Bad Soden, DE;

Inventors:

Dirk Stenkamp, Biberach, DE;

Stephan Georg Mueller, Warthausen, DE;

Gerald Juergen Roth, Biberach, DE;

Philipp Lustenberger, Warthausen, DE;

Klaus Rudolf, Warthausen, DE;

Thorsten Lehmann-Lintz, Ochsenhausen, DE;

Kirsten Arndt, Biberach, DE;

Ralf Lotz, Schemmerhofen, DE;

Martin Lenter, Ulm, DE;

Heike-Andrea Wieland, Bad Soden, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07C 233/29 (2006.01); C07C 235/24 (2006.01); C07C 255/60 (2006.01); C07D 209/18 (2006.01); C07D 211/14 (2006.01); C07D 213/56 (2006.01); C07D 295/092 (2006.01); C07D 401/12 (2006.01); C07D 413/12 (2006.01); A61K 31/167 (2006.01); A61K 31/40 (2006.01); A61K 31/4453 (2006.01); A61K 31/445 (2006.01); A61K 31/404 (2006.01); A61P 3/04 (2006.01); A61P 13/02 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to amide compounds of general formula I wherein the groups and residues A, B, b, W, X, Y, Z, R, Rand Rhave the meanings given in claim. Moreover the invention relates to pharmaceutical compositions containing at least one amide according to the invention. In view of the MCH receptor-antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.


Find Patent Forward Citations

Loading…